Skip to content
Welcome, thoughtbot's Giant Robots listeners!Start here
UK Startups and Innovation
22OCT

Science advisers ask Narayan for an AI Sovereignty Plan

2 min read
16:30UTC

The Council for Science and Technology warned the UK risks becoming a high-value AI customer and asked for one accountable owner of sovereignty choices.

TechnologyAssessed
Key takeaway

The CST wants one named owner for Britain's choices on AI sovereignty.

The Council for Science and Technology (CST), which advises the Prime Minister on science policy, warned that "without deliberate and urgent action, the UK risks becoming a high-value AI customer, rather than a country able to shape the technology"⁠1. The letter from co-chairs Dame Angela McLean and Lord Browne of Madingley to AI minister Kanishka Narayan is dated 30 July and appeared on gov.uk on 19 October.

It asks for a UK AI Sovereignty Plan that starts by mapping compute, data, skills, models and adoption, then decides what Britain should own, share or simply secure access to. It wants a single accountable owner for those choices, "such as the head of the Cabinet Office AI Taskforce". It also wants national compute allocated to pilots, including the Alan Turing Institute's proposal for an open-source base model that startups could build on.

In a City AM piece in July, Narayan pitched global AI leadership and Quantexa's John Harms answered that sovereignty needs governance control. The letter went up 81 days after it was written, four days after the British Business Bank's fund commitments under an "AI makers" banner.

Deep Analysis

In plain English

The Council for Science and Technology is a group of senior scientists and business leaders who advise the Prime Minister. It wrote to Kanishka Narayan, the government's minister for artificial intelligence. The letter says Britain risks becoming a big buyer of AI made elsewhere instead of a country that shapes it. It asks the government to work out which parts of AI Britain needs to own and to put one person in charge of those choices. The letter was written on 30 July but only published on 19 October.

Deep Analysis
Root Causes

AI policy in Britain is split across several departments and bodies: the Cabinet Office, the business and science department, UKRI and the Sovereign AI Unit. Each holds a piece of compute, data or funding, so no one is answerable for the overall mix.

The UK also depends on American model developers and chip suppliers for the most capable systems. That dependence is why the letter asks what Britain should secure access to rather than build.

What could happen next?
  • Consequence

    A named accountable owner would give Parliament one office to question on AI sovereignty spending.

  • Opportunity

    The Alan Turing Institute's open-source base model would give British startups a model to build on without licensing an American one, if national compute is allocated to it.

First Reported In

Update #16 · Stryker agrees option to buy CMR Surgical

Council for Science and Technology· 22 Oct 2026
Read original →
Causes and effects
This Event
Science advisers ask Narayan for an AI Sovereignty Plan
The Prime Minister's science advisers want someone in government to decide which AI capabilities Britain owns, shares or buys.
Different Perspectives
Abu Dhabi Investment Council
Abu Dhabi Investment Council
The Abu Dhabi Investment Council holds notes in Nscale's $3.36bn pre-IPO raise, beside Third Point, Apollo, Citadel and Nvidia. No British institution appears among the named holders of notes that convert into shares at Nscale's New York listing.
CDP Venture Capital
CDP Venture Capital
CDP Venture Capital, the venture arm of Italy's state lender, led TrueLayer's £20.4m round to expand Pay by Bank across Europe. A foreign state investor set the terms on a London fintech round in the same month the British Business Bank mostly followed.
EDBI
EDBI
Singapore's state investor EDBI joined Universal Quantum's Series A of more than $100m, and the Sussex company is opening its first research centre outside Europe in Singapore. British state money is absent from the largest Series A by a UK quantum company.
Forbion
Forbion
Forbion co-led OMass Therapeutics' $310m Series C with Bain Capital Life Sciences and Novo Holdings, while the British Business Bank and Syncona followed. The terms of the Oxford spinout's round were set by investors from three countries, none of them Britain.
British Business Bank
British Business Bank
The Bank committed £180m to six AI funds on 15 October with no UK-deployment condition, yet led the first close of Microbiotica's £36m Series C. That lead, with Airtel Money choosing London for its £5.3bn debut, is the evidence that British money and markets still set some terms.
Stryker Corporation
Stryker Corporation
Stryker called its roughly $400m CMR Surgical deal its entry into soft-tissue robotics, taking US sales rights for Versius, a board seat and an exclusive option over 100% of the company. The option lets Stryker choose whether and when a Cambridge robot maker becomes part of an American group.

Written with AI from Lowdown's published reporting. Not individually reviewed by an editor. Editorial standards.